stockrowAlcon
ALC Healthcare Medical Instruments & Supplies
Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024.
- Revenue
- +8.74%
- EPS
- −100.0%
- Free cash flow
- −0.54%
- Total debt
- −0.55%
Quarter to June 2026, against a year earlier
Follow ALC
Alert me
Alcon (ALC) Revenue growth
Alcon's revenue growth over the twelve months to 30 June 2026 was 8.34%, up 3.4 percentage points from fiscal 2025 (4.94%). Over the past ten years it has ranged from −8.99% (fiscal 2020) to 21.3% (fiscal 2021); the current reading is higher than 50% of that period. That is below the Medical Instruments & Supplies industry median of 8.97% and above the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 4.94% | 0.12 |
| FY2024 | 4.82% | (3.65) |
| FY2023 | 8.47% | 3.33 |
| FY2022 | 5.14% | (16.20) |
| FY2021 | 21.3% | 30.33 |
| FY2020 | −8.99% | (13.95) |
| FY2019 | 4.96% | 0.10 |
| FY2018 | 4.86% | (2.22) |
| FY2017 | 7.08% | 13.69 |
| FY2016 | −6.61% | — |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2026 | 8.74% | (0.68) |
| Mar 2026 | 9.42% | 0.79 |
| Dec 2025 | 8.63% | 2.11 |
| Sep 2025 | 6.52% | 2.51 |
| 28 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| WST West Pharmaceutical Services, Inc. compare | 12.6% |
| RMD ResMed Inc. compare | 9.04% |
| ALC Alcon | 8.34% |
| BAX Baxter International Inc. compare | 5.33% |
| COO The Cooper Companies, Inc. compare | 4.73% |
| ALGN Align Technology, Inc. compare | 4.42% |
| BDX Becton, Dickinson and Company compare | −2.55% |
| SOLV Solventum Corporation compare | −2.84% |
| MDLN Medline Inc. compare | — |
| Medical Instruments & Supplies industry median | 8.97% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on ALC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Beneish M-score
- The full statement